Target intelligence / Profile preview

NFYC pseudogene 1 (NFYCP1)

Target: NFYCP1
Molecular classification: Other (Pseudogene)

Overview

NFYC pseudogene 1 is a genomic region classified as a pseudogene due to its similarity to the NFYC gene but lack of protein-coding potential. Pseudogenes like NFYCP1 are generally considered non-functional remnants of gene duplication or retrotransposition events. While some pseudogenes have regulatory roles, there is no evidence that NFYCP1 is expressed or functionally significant. NFYCP1 is not considered a therapeutic target, receptor, enzyme, transporter, or other class of actionable molecule; thus, it is usually excluded from lists of drug targets and clinical biomarkers.

Other names: NFYC-P1

Mechanism of action

Not applicable.

Biological functions

May act as a miRNA decoy or be involved in the regulation of parental gene expression through mechanisms such as RNA interference (potentially participating in post-transcriptional regulation of NFYC), though this has not been specifically demonstrated for NFYCP1.Pseudogenes can sometimes influence gene expression by competing for trans-acting regulatory factors or forming antisense transcripts, but many remain transcriptionally silent.

Disease associations

No established disease role for NFYCP1.Some pseudogenes can act as regulators or be implicated in cancer or disease via their non-coding RNA activity, but no data directly support this for NFYCP1.

Beyond the preview

Go deeper on NFYC pseudogene 1 (NFYCP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NFYC pseudogene 1 (NFYCP1).

Explore the full profile